Foliglurax
id:
foliglurax-318-230664
title:
Foliglurax
text:
Foliglurax (developmental code names PXT-002331, DT2331) is a positive allosteric modulator of the metabotropic glutamate receptor 4 (mGluR4), which is under development by Prexton Therapeutics for the treatment of Parkinson's disease. It reached phase II clinical trials, but while it was found to be safe and showed some signs of clinical improvement, it failed to sufficiently distinguish itself from placebo to meet the study endpoints.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Foliglurax
date created:
date modified:
2023-07-10T13:18:14Z
main entity:
{"identifier":"Q39050138","url":"https://www.wikidata.org/entity/Q39050138"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2b/Foliglurax_tautomer_skeletal.svg","width":660,"height":278}
fields total:
13
integrity:
15